abstract |
The present invention relates to a method of treating IFN- [gamma] mediated diseases by administering a pharmaceutically effective amount of an antibody that interacts or binds with human interferon-gamma (IFN- [gamma]) and an antibody against IFN- [gamma]. The invention also provides a method for detecting the amount of IFN-γ in a sample using an antibody against IFN-γ. |